Heyu Biological Technology Corporation
HYBTOTCHealthcare
$0.35
$-0.25(-41.67%)
Market Cap$361364506
P/E Ratio—
52W High$3.4
52W Low$0.002
Heyu Biological Technology Corporation (HYBT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HYBT · earnings · updated Jun 8, 2026
Latest Earnings
Q3 FY2025Report Date: Aug 14, 2025EPS Actual
$0.00
Revenue
$0.00B
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Aug 14, 2025
After Market Close
HYBT reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2025 | Aug 14, 2025 | — | $0.00 | — | $0.00B | — | — |
| — Q1 FY2025 | Mar 28, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2024 | Nov 13, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2024 | Aug 13, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2024 | May 15, 2024 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2024 | Apr 1, 2024 | — | $0.00 | — | $0.00B | — | — |
| — Q4 FY2023 | Nov 14, 2023 | — | -$0.00 | — | $0.00B | — | — |
| — Q3 FY2023 | Aug 16, 2023 | — | -$0.00 | — | $0.00B | — | — |
Q3 FY2025
Aug 14, 2025
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Mar 28, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Nov 13, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Aug 13, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
May 15, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Apr 1, 2024
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2023
Nov 14, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2023
Aug 16, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2025 | Aug 14, 2025 | — | $0.29 | — | — |
| — Q1 FY2025 | Mar 28, 2025 | — | $0.29 | — | — |
| — Q4 FY2024 | Nov 13, 2024 | — | $0.29 | — | — |
| — Q3 FY2024 | Aug 13, 2024 | — | $0.29 | — | — |
| — Q2 FY2024 | May 15, 2024 | — | $0.29 | — | — |
| — Q2 FY2024 | Apr 1, 2024 | — | $0.29 | — | — |
| — Q4 FY2023 | Nov 14, 2023 | — | $0.60 | $0.60 | +0.00% |
| — Q3 FY2023 | Aug 16, 2023 | — | $2.00 | $1.00 | -50.00% |
Q3 FY2025—
Report Date
Aug 14, 2025
EPS Beat/Miss
—
Price Before
$0.29
Price After
—
Q1 FY2025—
Report Date
Mar 28, 2025
EPS Beat/Miss
—
Price Before
$0.29
Price After
—
Q4 FY2024—
Report Date
Nov 13, 2024
EPS Beat/Miss
—
Price Before
$0.29
Price After
—
Q3 FY2024—
Report Date
Aug 13, 2024
EPS Beat/Miss
—
Price Before
$0.29
Price After
—
Q2 FY2024—
Report Date
May 15, 2024
EPS Beat/Miss
—
Price Before
$0.29
Price After
—
Q2 FY2024—
Report Date
Apr 1, 2024
EPS Beat/Miss
—
Price Before
$0.29
Price After
—
Q4 FY2023+0.00%
Report Date
Nov 14, 2023
EPS Beat/Miss
—
Price Before
$0.60
Price After
$0.60
Q3 FY2023-50.00%
Report Date
Aug 16, 2023
EPS Beat/Miss
—
Price Before
$2.00
Price After
$1.00
Beat Rate0 / 8 quarters
Largest Move-50.00% (Q3 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HYBT ends December
Heyu Biological Technology Corporation (HYBT) most recently reported earnings on August 14, 2025 for Q3 FY2025, posting EPS of $0.00 (in line with the analyst consensus of —). The next HYBT earnings date is expected around September 1, 2026.
Each quarter, investors track HYBT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HYBT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HYBT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HYBT earnings · 4 questionsHeyu Biological Technology Corporation's next earnings report is expected around September 1, 2026. HYBT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HYBT historically reports after market close (AMC).
HYBT earnings datewhen is HYBT earningsHYBT next earnings datewhen does HYBT report earningsHYBT earnings calendar
▸ Source: FMP · Heyu Biological Technology Corporation SEC filings · US GAAP · Heyu Biological Technology Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026